Medical Developments International LtdShs Aktie
| 0,35USD | -0,04USD | -9,61% |
WKN: A0BLXB / ISIN: AU000000MVP2
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 82,84 |
| David John Williams | 5,60 |
| Lawn Views Pty Ltd. | 5,38 |
| FIL Investment Management (Hong Kong) Ltd. | 4,28 |
| Fidelity Funds SICAV - Pacific Fund | 2,59 |
| Netwealth Investments Ltd. | 2,49 |
| FIL Investment Management (Australia) Ltd. | 2,46 |
| Russell Kay Hancock | 1,56 |
| Gordon Naylor, MBA, CPA | 1,16 |
| M&G Investment Funds (3) - Recovery Fund | 1,00 |
| Kidder Peabody Pty Ltd. | 0,95 |
| NEF - Pacific Equity | 0,83 |
| Payne Media Pty Ltd. | 0,78 |
| Fidelity Australian High Conviction Fund | 0,77 |
| Alistair William Strong | 0,57 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 65 | 68 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,35 | 0,37 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. AUD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 26 | 47 | 34 | 43 | 26 |
| Summe Anlagevermögen | 69 | 53 | 67 | 67 | 38 |
| Summe Aktiva | 95 | 100 | 101 | 109 | 64 |
Bilanz (in Mio. AUD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 3 | 3 | 3 | 3 | 2 |
| Summe Fremdkapital | 52 | 32 | 44 | 28 | 18 |
| Summe Eigenkapital | 43 | 68 | 57 | 81 | 46 |
| Summe Passiva | 95 | 100 | 101 | 109 | 64 |
Adresse
| 4 Caribbean Drive, 3179 Scoresby | |
| Telefon | +61 (3) 9547-1888 |
| Fax | +61 (3) 9547-0262 |
| Internet | http://www.medicaldev.com |
Management
|
Anastasia Tan
Head-Operations & Supply Chain |
|
Anita James
Chief Financial Officer |
|
Brent MacGregor
Chief Executive Officer |
|
Christine Emmanuel-Donnelly
Independent Non-Executive Director |
|
Damian Meagher
Head-Quality & Regulatory Affairs |
|
Gordon Naylor
Non-Executive Chairman |
|
Leon Gregory Hoare
Independent Non-Executive Director |
|
Mary Sontrop
Non-Executive Director |
|
Richard Betts
Non-Executive Director |
|
Russell Basser
Director |
|
Scott Courtney
Chief Scientific Officer |
|
Sue Anne Yee
Head-Medical Affairs & Clinical Development |
|
Tara Eaton
Secretary & General Counsel |
|
Tony Wheal
Head-People & Culture |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
